Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI

Abroad (travel likely)Recruiting

Conditions

Coronary Artery Disease · Acute Kidney Injury · Contrast-Induced Acute Kidney Injury · Percutaneous Coronary Intervention

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Collegium Medicum w Bydgoszczy, Bydgoszcz, Poland
Contact: Study coordinator (Piotr Niezgoda, MD, PhD) · piotr.niezgoda1986@gmail.com · +48525854023

Study leads

Jacek Kubica, Prof.
Principal Investigator
Collegium Medicum w Bydgoszczy

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Coronary Artery Disease · Percutaneous Coronary Intervention · Acute Coronary Syndrome

Abroad (travel likely)RecruitingPHASE4

Anyang, South Korea · Bucheon-si, South Korea

CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

Coronary · Coronary Artery Disease

Abroad (travel likely)RecruitingPHASE4

Chengdu, China

Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

Myocardial Infarction

Abroad (travel likely)Recruiting

Shibīn al Kawm, Egypt

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Coronary Artery Disease

Abroad (travel likely)RecruitingPHASE4

Bucheon-si, South Korea · Busan, South Korea